The 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thione derivatives were synthesized by Bajaj et al. and evaluated their anticancer potential (on the breast cancer cell line (MCF-7) for thymidine phosphorylase inhibition activity. Here, TYMP is linked to breast carcinoma.